Press Releases
October 24 2024
InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories
October 10 2024
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
October 01 2024
InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
September 10 2024
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
September 04 2024
InMode to Present at 2024 Baird Global Healthcare Conference
August 06 2024
InMode to Present at Upcoming Investor Conferences
August 01 2024
InMode Reports Q2 2024 Financial Results; Quarterly Revenue of $86.4M
July 31 2024
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
July 17 2024
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
July 11 2024
InMode to Report Q2 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
